Q4 2022 Nautilus Biotechnology Inc Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Nautilus Biotechnology Q4 and Full Year 2022 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
And it is now my pleasure to introduce your first speaker today, Alex Conn, Investor Relations of Nautilus Biotechnology. Please go ahead.
Thank you. Earlier today, Nautilus released financial results for the quarter and full year ended December 31, 2022. If you haven't received this news release or if you'd like to be added to the company's distribution list, please send an e-mail to [email protected].
Joining me today from Nautilus are Sujal Patel, Co-Founder and CEO; and Adam Mowry, Chief Financial Officer. Nautilus Co-Founder and Chief Scientist, Parag Mallick, will be joining us for Q&A.
Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking within the meaning of the federal securities laws. These statements
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |